Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0T4GZ
|
||||
Former ID |
DIB003338
|
||||
Drug Name |
MPL-S
|
||||
Indication | Endotoxic shock [ICD10:R57.8] | Phase 3 | [1] | ||
Company |
Ribi ImmunoChem Research Inc
|
||||
Target and Pathway | |||||
Target(s) | Nitric oxide synthase, inducible | Target Info | Modulator | [2] | |
BioCyc Pathway | Citrulline-nitric oxide cycle | ||||
KEGG Pathway | Arginine biosynthesis | ||||
Arginine and proline metabolism | |||||
Metabolic pathways | |||||
Calcium signaling pathway | |||||
HIF-1 signaling pathway | |||||
Peroxisome | |||||
Salmonella infection | |||||
Pertussis | |||||
Leishmaniasis | |||||
Chagas disease (American trypanosomiasis) | |||||
Toxoplasmosis | |||||
Amoebiasis | |||||
Tuberculosis | |||||
Pathways in cancer | |||||
Small cell lung cancer | |||||
NetPath Pathway | IL1 Signaling Pathway | ||||
IL2 Signaling Pathway | |||||
Pathway Interaction Database | IL12-mediated signaling events | ||||
Alpha9 beta1 integrin signaling events | |||||
ATF-2 transcription factor network | |||||
IL23-mediated signaling events | |||||
Signaling mediated by p38-alpha and p38-beta | |||||
HIF-1-alpha transcription factor network | |||||
Reactome | ROS production in response to bacteria | ||||
Nitric oxide stimulates guanylate cyclase | |||||
WikiPathways | Type II interferon signaling (IFNG) | ||||
Spinal Cord Injury | |||||
AGE/RAGE pathway | |||||
Effects of Nitric Oxide | |||||
References | |||||
REF 1 | ClinicalTrials.gov (NCT00699764) Safety of a Herpes Simplex Candidate Vaccine (gD2t) With MPL and Its Efficacy to Prevent Genital Herpes Disease. U.S. National Institutes of Health. | ||||
REF 2 | Lipopolysaccharide and monophosphoryl lipid A differentially regulate interleukin-12, gamma interferon, and interleukin-10 mRNA production in murine macrophages. Infect Immun. 1997 Aug;65(8):3239-47. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.